Error in Figure/Table
In the published article, there was an error in Figure 1 as published. Many words in Figure 1 appeared underlined. The corrected Figure 1 and its caption appear below.
Figure 1
Algorithm to choose a monoclonal antibody.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Summary
Keywords
T2 severe asthma, monoclonal antibodies, biomarkers, exacerbations, systemic corticosteroids
Citation
López-Viña A, Diaz Campos RM, Trisan Alonso A and Melero Moreno C (2023) Corrigendum: Uncontrolled severe T2 asthma: Which biological to choose? A biomarker-based approach. Front. Allergy 3:1119941. doi: 10.3389/falgy.2022.1119941
Received
09 December 2022
Accepted
15 December 2022
Published
10 January 2023
Approved by
Frontiers in Allergy Editorial Office, Frontiers Media SA, Switzerland
Volume
3 - 2022
Updates
Copyright
© 2023 López-Viña, Díaz Campos, Trisan Alonso and Melero Moreno.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Rocio M. Diaz Campos rociomdc80@gmail.com
Specialty Section: This article was submitted to Asthma, a section of the journal Frontiers in Allergy
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.